Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation.

Saved in:
Bibliographic Details
Title: Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation.
Authors: Gorelik A; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. andrii.gorelik@path.ox.ac.uk., Đukić N; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Smith R; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Chatrin C; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Suyari O; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK., Matthews J; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, 0317, Oslo, Norway.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada., Ahel I; Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. ivan.ahel@path.ox.ac.uk.
Source: The EMBO journal [EMBO J] 2026 Jan; Vol. 45 (1), pp. 261-277. Date of Electronic Publication: 2025 Dec 01.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1460-2075
DOI:10.1038/s44318-025-00656-1